Literature DB >> 21320615

Osteoarthritis year 2010 in review: pharmacological therapies.

F Berenbaum1.   

Abstract

This review highlights a selection of original studies related to the treatment of osteoarthritis in 2010.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21320615     DOI： 10.1016/j.joca.2011.01.019

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN： 1063-4584            Impact factor:   6.576


  16 in total

1.  P2X3 and P2X2/3 Receptors Play a Crucial Role in Articular Hyperalgesia Development Through Inflammatory Mechanisms in the Knee Joint Experimental Synovitis.

Authors:  Juliana Maia Teixeira; Franciane Bobinski; Carlos Amílcar Parada; Kathleen A Sluka; Cláudia Herrera Tambeli
Journal:  Mol Neurobiol       Date:  2016-10-05       Impact factor: 5.590

2.  Efficacy and safety of aceclofenac in osteoarthritis: A meta-analysis of randomized controlled trials.

Authors:  Parvati B Patel; Tejas K Patel
Journal:  Eur J Rheumatol       Date:  2017-03-01

3.  Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis.

Authors:  José Roberto Provenza; Samuel Katsuyuki Shinjo; Joyce Macedo Silva; Carla Rosana Goulart Silva Peron; Francisco Airton Castro Rocha
Journal:  Clin Rheumatol       Date:  2014-08-03       Impact factor: 2.980

4.  Systemic neutralization of TGF-β attenuates osteoarthritis.

Authors:  Liang Xie; Francis Tintani; Xiao Wang; Fengfeng Li; Gehua Zhen; Tao Qiu; Mei Wan; Janet Crane; Qianming Chen; Xu Cao
Journal:  Ann N Y Acad Sci       Date:  2016-02-02       Impact factor: 5.691

5.  Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone.

Authors:  Zhuang Cui; Janet Crane; Hui Xie; Xin Jin; Gehua Zhen; Changjun Li; Liang Xie; Long Wang; Qin Bian; Tao Qiu; Mei Wan; Min Xie; Sheng Ding; Bin Yu; Xu Cao
Journal:  Ann Rheum Dis       Date:  2015-10-15       Impact factor: 19.103

6.  A putative Chondroprotective role for IL-1β and MPO in herbal treatment of experimental osteoarthritis.

Authors:  Nora M Aborehab; Mahitab H El Bishbishy; Abeer Refaiy; Nermien E Waly
Journal:  BMC Complement Altern Med       Date:  2017-11-22       Impact factor: 3.659

7.  Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis.

Authors:  Gehua Zhen; Chunyi Wen; Xiaofeng Jia; Yu Li; Janet L Crane; Simon C Mears; Frederic B Askin; Frank J Frassica; Weizhong Chang; Jie Yao; John A Carrino; Andrew Cosgarea; Dmitri Artemov; Qianming Chen; Zhihe Zhao; Xuedong Zhou; Lee Riley; Paul Sponseller; Mei Wan; William Weijia Lu; Xu Cao
Journal:  Nat Med       Date:  2013-05-19       Impact factor: 53.440

8.  Cartilage Protective and Chondrogenic Capacity of WIN-34B, a New Herbal Agent, in the Collagenase-Induced Osteoarthritis Rabbit Model and in Progenitor Cells from Subchondral Bone.

Authors:  Jeong-Eun Huh; Yeon-Cheol Park; Byung-Kwan Seo; Jae-Dong Lee; Yong-Hyeon Baek; Do-Young Choi; Dong-Suk Park
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-01       Impact factor: 2.629

9.  Angelica Sinensis polysaccharides stimulated UDP-sugar synthase genes through promoting gene expression of IGF-1 and IGF1R in chondrocytes: promoting anti-osteoarthritic activity.

Authors:  Yinxian Wen; Jing Li; Yang Tan; Jun Qin; Xianfei Xie; Linlong Wang; Qibing Mei; Hui Wang; Jacques Magdalou; Liaobin Chen
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

10.  Cannabinoid CB2 receptors regulate central sensitization and pain responses associated with osteoarthritis of the knee joint.

Authors:  James J Burston; Devi Rani Sagar; Pin Shao; Mingfeng Bai; Emma King; Louis Brailsford; Jenna M Turner; Gareth J Hathway; Andrew J Bennett; David A Walsh; David A Kendall; Aron Lichtman; Victoria Chapman
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.